AZN vs PEBO · P/E 28, $288.38B cap vs P/E 11, rev $44.4M
AstraZeneca PLC (AZN) versus Peoples Bancorp Inc (PEBO) — a side-by-side from cached financials, not a winner call.
AstraZeneca PLC (AZN) is a drug manufacturers - general company listed on US.
Peoples Bancorp Inc (PEBO) is a banks - regional company listed on NASDAQ.
AZN does not have a complete income-statement cache yet.
Latest reported PEBO revenue for 2026-06-30 was $44.4M. Net income was $57.0M. Revenue was up 98.6% from 2026-03-31 to 2026-06-30. PEBO currently screens at market cap $1.28B and trailing P/E 11.5.
AZN currently screens at market cap $288.38B and trailing P/E 28.0. PEBO currently screens at market cap $1.28B and trailing P/E 11.5.
Not investment advice. Open the AZN and PEBO stock pages for the full models.
Not investment advice.